FdaApplication

NDA 022028

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSANDOZ INC
application_typeNDA
approval_date2008-02-21

Products (1)

ProductActive ingredientStrengthDosage form
COSYNTROPINCOSYNTROPIN0.25MG/ML (0.25MG/ML)SOLUTION;INTRAVENOUS

1 product